ATE364704T1 - Mutanten von op-1 - Google Patents

Mutanten von op-1

Info

Publication number
ATE364704T1
ATE364704T1 AT99954771T AT99954771T ATE364704T1 AT E364704 T1 ATE364704 T1 AT E364704T1 AT 99954771 T AT99954771 T AT 99954771T AT 99954771 T AT99954771 T AT 99954771T AT E364704 T1 ATE364704 T1 AT E364704T1
Authority
AT
Austria
Prior art keywords
proteins
finger
domain
sub
tgf
Prior art date
Application number
AT99954771T
Other languages
English (en)
Inventor
Hermann Oppermann
Mei-Sheng Tai
John Mccartney
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stryker Corp filed Critical Stryker Corp
Application granted granted Critical
Publication of ATE364704T1 publication Critical patent/ATE364704T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99954771T 1998-10-07 1999-10-07 Mutanten von op-1 ATE364704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10341898P 1998-10-07 1998-10-07
US09/374,958 US6677432B1 (en) 1998-10-07 1999-08-16 Mutations of the C-terminal portion of TGF-β superfamily proteins

Publications (1)

Publication Number Publication Date
ATE364704T1 true ATE364704T1 (de) 2007-07-15

Family

ID=26800441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954771T ATE364704T1 (de) 1998-10-07 1999-10-07 Mutanten von op-1

Country Status (8)

Country Link
US (1) US6677432B1 (de)
EP (1) EP1117804B1 (de)
JP (3) JP3971107B2 (de)
AT (1) ATE364704T1 (de)
AU (1) AU772930B2 (de)
CA (1) CA2344974C (de)
DE (1) DE69936312T2 (de)
WO (1) WO2000020607A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1225225A3 (de) * 1988-04-08 2003-01-08 Stryker Corporation Osteogene Vorrichtungen
US6586388B2 (en) * 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US6919308B2 (en) * 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
EP0876401B1 (de) * 1996-01-22 2007-06-13 Curis, Inc. Methoden zur herstellung von op-1 morphogen analoge
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
US7211644B1 (en) * 1996-08-27 2007-05-01 University Of South Florida Diagnostic markers of human female infertility
US8106001B2 (en) * 1996-08-27 2012-01-31 University Of South Florida Diagnostic markers of human female infertility
US6683156B1 (en) 1996-08-27 2004-01-27 University Of South Florida Method for diagnosing selected adenocarcinomas
US6294662B1 (en) 1996-08-27 2001-09-25 University Of South Florida Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
EP2128260A3 (de) * 1998-10-07 2010-06-16 STRYKER CORPORATION (a Michigan corporation) Modifizierte TGF-beta-Superfamilienproteine
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
JP4685294B2 (ja) * 2001-09-18 2011-05-18 株式会社カネカ 新規ペプチド、生産方法、新規吸着体、吸着器および吸着方法
EP2392659B1 (de) * 2002-06-17 2015-01-14 Thrasos Innovation, Inc. TDF-zugehörige Einzeldomänenverbindungen und Analoge davon
AU2003283155A1 (en) 2002-11-14 2004-06-03 Adherex Technologies Inc. Compounds and methods for modulating functions of classical cadherins
CA2561809A1 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
US7795389B2 (en) 2004-09-28 2010-09-14 The Board Of Regents Of The University Of Texas System Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins
EP1698691A1 (de) * 2005-03-04 2006-09-06 Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH Mutanten von Wachstumsfaktoren mit verbesserter biologischer Eigenschaft
ATE520711T1 (de) * 2005-05-27 2011-09-15 Bbs Bioactive Bone Substitutes Oy Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten
US7659250B2 (en) * 2005-12-22 2010-02-09 Centocor, Inc. BMP-7 variant compositions, methods and uses
GB0604938D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
WO2008014054A2 (en) * 2006-07-27 2008-01-31 Centocor, Inc. Bmp-7 variant compositions, methods and uses
CA2671925A1 (en) 2006-12-21 2008-07-10 Stryker Corporation Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
EP2396026A2 (de) 2009-02-12 2011-12-21 Stryker Corporation Zusammensetzungen und verfahren für die minimal invasive systemische abgabe von proteinen einschliesslich mitglieder der tgf-superfamilie
EP2396025A2 (de) 2009-02-12 2011-12-21 Stryker Corporation Periphere verabreichung von proteinen einschliesslich mitglieder der tgf-beta-superfamilie zur systemischen behandlung von störungen und erkrankungen
EP2401293B1 (de) 2009-02-24 2016-02-10 The Salk Institute For Biological Studies Designer-liganden der tgf-beta-superfamilie
WO2010110974A1 (en) 2009-03-24 2010-09-30 Stryker Corporation Methods and compositions for tissue engineering
WO2011031856A1 (en) 2009-09-09 2011-03-17 Stryker Corporation Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
AU2010295509A1 (en) 2009-09-17 2012-04-19 Stryker Corporation Buffers for controlling the pH of bone morphogenetic proteins
JP2013514811A (ja) 2009-12-22 2013-05-02 ストライカー コーポレイション 免疫原性が抑制されたbmp−7変異体
CU24181B1 (es) * 2012-11-09 2016-04-25 Ct De Inmunología Molecular POLIPÉPTIDOS DERIVADOS DEL TGFß
CN107847638A (zh) 2014-12-29 2018-03-27 佰欧维恩图斯有限责任公司 用于骨修复中改善骨诱导性分子递送的***和方法
CA2995310A1 (en) 2015-08-25 2017-03-02 Histide Ag Compounds for inducing tissue formation and uses thereof
US20190016770A1 (en) * 2015-08-25 2019-01-17 Histide Ag Compounds for inducing tissue formation and uses thereof
EP3464337A4 (de) 2016-05-31 2019-12-18 Mogam Institute for Biomedical Research Ab6-familie-designerliganden der tgf-beta-superfamilie
JPWO2020095894A1 (ja) * 2018-11-05 2021-10-07 味の素株式会社 フローマイクロリアクターを用いるリフォールディングされたタンパク質の製造方法及びタンパク質のリフォールディング装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250302A (en) 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
DK0448704T3 (da) 1989-10-17 1999-04-06 Stryker Corp Osteogene anordninger
JPH05501500A (ja) 1989-10-18 1993-03-25 クリエイティブ・バイオマリキュールズ・インコーポレーテッド TGF―βの生合成構築物
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5071655A (en) * 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
WO1992015323A1 (en) 1991-03-11 1992-09-17 Creative Biomolecules, Inc. Protein-induced morphogenesis
DE4131545C2 (de) 1991-09-21 1995-02-02 Krupp Industrietech Federbein für hydraulischen Radantrieb
WO1994015949A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-5
CA2165776A1 (en) 1993-07-09 1995-01-19 Se-Jin Lee Growth differentiation factor-6
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
ES2255059T3 (es) 1993-12-07 2006-06-16 Genetics Institute, Llc Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
FR2720069A1 (fr) 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
US5674292A (en) 1995-06-07 1997-10-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof

Also Published As

Publication number Publication date
WO2000020607A9 (en) 2001-03-29
CA2344974A1 (en) 2000-04-13
AU772930B2 (en) 2004-05-13
WO2000020607A2 (en) 2000-04-13
AU1103800A (en) 2000-04-26
WO2000020607A3 (en) 2000-07-06
JP2002526115A (ja) 2002-08-20
JP5149070B2 (ja) 2013-02-20
JP2008237223A (ja) 2008-10-09
JP2005290016A (ja) 2005-10-20
EP1117804B1 (de) 2007-06-13
DE69936312D1 (de) 2007-07-26
CA2344974C (en) 2011-03-29
DE69936312T2 (de) 2008-02-14
JP4294010B2 (ja) 2009-07-08
EP1117804A2 (de) 2001-07-25
JP3971107B2 (ja) 2007-09-05
US6677432B1 (en) 2004-01-13

Similar Documents

Publication Publication Date Title
DE69936312D1 (de) Mutanten von op-1
EP2128260A3 (de) Modifizierte TGF-beta-Superfamilienproteine
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
DE69434299D1 (de) Nukleoside und oligonukleoside mit thiol-gruppe
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
EE9800306A (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
DE69937291D1 (de) Antikörper varianten und fragmente davon
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
WO2003000853A3 (en) Protein aggregation assays and uses thereof
DE69839444D1 (de) Smad 6 und dessen anwendungen
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
ATE348159T1 (de) Mutierte mitglieder der tgf-beta-superfamilie, einschliesslich morphogenetischer proteine
SE8902532L (sv) Bestaemning av plasmaproteiner
FR2766193B1 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
DE69800720T2 (de) Reagenz zur Färbung von Blutzellen
ES2173471T3 (es) Analisis para homocisteina y homocisteina desulfurasa a partir de tricomonas viginalis de protozoos.
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
EP0749312A4 (de) DIROFILARIA IMMITIS - Gp29 - PROTEINE, NUKLEINSÄUREMOLEKÜLE UND IHRE VERWENDUNGEN
AU7147898A (en) (dirofilaria) and (brugia) ankyrin proteins, nucleic acid molecules, and uses thereof
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
TR199902434T2 (xx) Bakteriyel plazmidler.
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties